Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Published today about a "dead" drug and company? How can that be?
Washing your employment and deep connection with IPIX and Leo won’t save Lady Jane when the law comes knocking.
Fool. IPIX is dead.
I can't make hide nor hair out of the patent you posted and scanned thru it but didn't see anything saying Brilacidin so I have no clue if Bri is a major component of the treatment, a side issue that is nice but not imperative to the cure, or just what part Bri plays in the overall functioning of this new drug.
Hope we still have the rights to Bri for use in new patents.
Will wait for B Med information as that seems to be our brightest hope at the moment.
Thanks for posting this, though, as it does show some in the medical industry recognize the important Bri could play in a number of treatments.
Do you guys have another gig lined up????
"Could have sworn Barry Schechter and Zorik Spektor were both removed from the page."
They weren't. You're not suggesting that they are still on the Board, are you?
Do you think Leo Ehrlich is still CEO?
Could you have sworn that he was removed from the page as well? There hasn't been a filing reporting his resignation.
http://www.ipharminc.com/board-of-directors
When is your last day on this board???
PJ, PJ, PJ ! You just don’t know when to give up do you?
Stop wasting your time researching Brilacidin hoping for a miracle.
Loan rangers post:
Member Level
Re: olden_grumpini post# 401522
Thursday, 02/01/2024 11:36:53 AM
Gotta look at the bright side, -20% today and a share is only down one tenth of a penny, lol. Dead, dead, dead...
When is your last day on this board???
Last man standing. IPIX will never benefit from B, thanks to the incompetent, irresponsible, lying Ehrlich.
Another patent published today by Gilead that mentions Brilacidin.....
https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240131045
Ehrlich's ghost town website is so full of misinformation it should be taken down. Unfortunately, Ehrlich can't even undertake the simplest task, either because he is incompetent or just doesn't care. Everything is lost.
Ipix could go down 25% every day forever. Think about that.
It did. Still might. But as of now flies are gathering…..
when this hits zero we get nothing after that, then beamed goes public in OT with our 4M and no word of B
Could this happen?
http://www.ipharminc.com/board-of-directors
Could have sworn Barry Schechter and Zorik Spektor were both removed from the page.
Did she do so because of Leo or this cabal?
Oh wow. Thanks for the update. This had promise.
" ever question why 200k shares were just purchased?"
I figured you or one of the other loyalists stumbled over $460 in nickels in your couch cushions.
That size buy doesn't exactly scream "accredited investor".
"and now she is gone."
It LOOKS that way, but this cloak of silence that LE has donned leaves us guessing.
She (and he) could be continuing to collect their regular checks and just erasing their public connections to IPIX.
Did LE leave the Company checkbook behind?
Do you and the crew ever question why 200k shares were just purchased? It happens over and over.
Now we know it's not a delusional retail board member
Keep kicking the dead horse.
Makes me wonder who the sane people are around here.
Not much left but a dirty, cracked shell. Useless Jane is gone and Ehrlich has vanished. Assume he is the last one standing in this garbage dump he created. Shareholders left in the dark with little to no hope.
Wow. Got that right. The Ehrlich delete all failures technique. With no money left, I was wondering how long it would be before she departed and now she is gone.
And the genius French investor and scooper upper of IPIX shares has also vanished.
Jane Harness
Company name has been changed....in this case deleted....to try to protect a badly soiled reputation.
Guess she learned the benefits of scrubbing from her mentor.
Experience
Clinical Research & Project Management Consultant
2016 - Present · 8 yrs 4 mos
MA, USA
Vice President, Clinical OperationsVice President, Clinical Operations
Revance Therapeutics, Inc.Revance Therapeutics, Inc.
2014 - 2015 · 1 yr2014 - 2015 · 1 yr
Newark, CA, USANewark, CA, USA
Head of Clinical Sciences, Dermatology & ATI Translational Research
Novartis Institutes for BioMedical ResearchNovartis Institutes for BioMedical Research
2010 - 2014 · 4 yrs
Basel, SwitzerlandBasel, Switzerland
Clinical Lead/ Director
Pfizer
2002 - 2010 · 8 yrs
Led the overall clinical development of multiple Dermatology programs, oral and topical.Led the overall clinical development of multiple Dermatology programs, oral and topical.…see more
Note "2016 - Present"
I’ve always wondered why Leo couldn’t file Quarterly’s on his own when in Pink Status because of the following on the company profile section with the OTC:
“Mr. Ehrlich has over 25 years of executive leadership experience in building and managing emerging growth companies. Mr. Ehrlich is a Certified Public Accountant and received his BBA from Bernard Baruch College of the City University of New York.”
I guess he forgot how to do legitimate accounting work from the days of receiving his degree and Certification as a CPA!!!!!!!!
Who fired her? Who is making these decisions? Maybe it’s a suicidal firing?
That sounds very high tech. Do you think it’s therapeutic to deliver a drug whose efficacy hasn’t been established in a phase 3 study and FDA approved?
Thats good news....what exactly did she do except collect a check....the fat is getting trimmed.....Leo is next to go!!!!!!
I think we know very little about beamed, but the trading has dropped due to the listing change. Retail can no longer buy this, and since there is zero industry interest….
Guess which Senior Vice President, Clinical Sciences and Portfolio Management has deleted all traces of IPIX from her LinkedIn page?
I’ve been away from here for a long time and noticed there is zero on the bid and ask however shares are being traded.
Did this POS finally succumb?
Whatever happen to the merger with BeMed? Did the Iranian drones knocked them out of business?
Does BeMed still exist? The 2 principals are in the IDF reserves so did they get called up? If so, who is running the company? Please don’t tell me it is Ehrlich?
While I don’t claim to know what PJ007 was referring to the first thing that came to my mind was LADD (Laser Assisted Drug Delivery).
What is your reasoning for saying, “ they have the connections to advance Brilacidin”? How do you know that? Is there a connection between Laser development, software engineering and infectious disease and anti-microbials? This sounds more like “hope-e change-e” thinking and trying to keep your audience for company?
Exactly what Ehrlich did to the company and it's shareholders...You and Frenchbroad would make a good Ehrlich and Useless Jane.
Wonder if the End-of-the-Line Ehrlch is scanning the Shells Are Us pages looking for a someone to play the shell game...although there are probably cleaner shells listed on better markets than the garbage he has created.
https://dealstream.com/wanted/public-shells
Or perhaps they just soaked the idiot Ehrlich for $4 million and that is the end of it. What connections do the Laser Boys have to advance Brilacidin?
“A reverse merger with BeaMed and a name change with a new CEO is highly likely.“
I’m sure the laser boys are begging for the multi-million dollar judgement owed by IPIX. Dirty pecker has all your cash and is set to retire. End of story.
I told ya so. Many times. Many more to come.
You’re one of the few. Slurp it up.
“… and bagholders continue to suckle.”
🍒
Fixation?
IPIX is dead and bagholders continue to suckle. Slurp it up. Slurp. Slurp. Poor bastards. Fun to watch!
"By definition there are no investors left in IPiX, merely extremely ill-informed speculators."
(_*_)
Don’t imagine ipix has many accredited investors left?
Do you have any info from anyone that possibly confirms your thoughts or are you just trying to connect dots? I know his silence suggests he’s checked out, which could mean he’s just screwed us over! Hopefully that’s not the case
I believe Leo is done....announcement coming soon.....Laser boys are taking over.....they have the connections to advance Brilacidin......
Followers
|
980
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
402582
|
Created
|
05/10/08
|
Type
|
Free
|
Moderators zandant Minnesinger sunspotter snayeman loanranger frenchbroad |
Innovation Pharmaceuticals Inc. (IPIX)
$IPIX NEWS - http://ipharminc.com/press-release
SEC Filings https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
From the most recent 10-K:
There are doubts about our ability to continue as a going concern.
We have generated revenue of $0 and $18,000 for the fiscal years ended June 30, 2023 and 2022, respectively and have an accumulated deficit of $125.3 million through June 30, 2023. These factors raise substantial doubt about our ability to continue as a going concern.
We need to raise substantial additional capital in the future to fund our operations and we may be unable to raise such funds when needed and on acceptable terms, which could prevent us from fully implementing our business, operating and development plans.
We currently have an approximate $1.0 million cash balance as of the date of this filing, but that is insufficient to complete the development and commercialization of any of our proposed products. We expect to incur costs of approximately $1.8 million in the upcoming fiscal year ending June 30, 2024 to operate our business in accordance with our business plans and budgets.
We have limited experience in drug and formulation development, the conduct of clinical trials, and may not be able to successfully develop any drugs.
Development of pharmaceutical products is a risky and time-consuming process subject to a number of factors, many of which are outside of our control. We are subject to regulatory authority permissions and approvals, most importantly the FDA. Our drug candidate(s)/indications are at early and mid-stages of development. Consequently, we can provide no assurance of the successful and timely development of new drugs, and the failure to do so could cause us to cease operations.
We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock.
http://www.ipharminc.com/
About Innovation Pharmaceuticals Inc.:
Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal.
IPIX CEO - "The Company historically devoted most of its efforts and resources on business development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully." "In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials." Source - https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223003414/ipix_10q.htm
More information is available at http://www.ipharminc.com.
Management: http://www.ipharminc.com/senior-management/
Scientific Advisors: http://www.ipharminc.com/scientific-advisors/
Clinical Trials: https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Product Pipeline: http://www.ipharminc.com/therapeutic-areas/
Recent News and Press Releases:
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/
SEC Filings (CIK:0001355250): https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com
Share Structure: See SEC filing link above for current share structure
Investor Relations:
http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1
Chart: https://stockcharts.com/h-sc/ui?s=IPIX
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |